Sylvester Comprehensive Cancer Center


Eckhard Podack, M.D., Ph.D., left, and Joseph Rosenblatt, M.D.

FDA Approves New Lymphoma Drug Based on Miller School Research


Offering hope to lymphoma patients who have exhausted their treatment options, the Food and Drug Administration just approved a new drug which was based on an antibody developed at the Miller School of Medicine and has proven effective in recent clinical trials against Hodgkin’s lymphoma (HL) and anaplastic large cell lymphoma (ALCL) in patients for whom standard therapies failed.

Gustavo Fernandez, M.D., the study’s principal investigator, readies patient Robert Chambers for his last dose of the promising drug.

Out of Options, First Patient in Bladder Cancer Trial Now Has Hope


When Robert Chambers became the first patient to receive a potential new bladder cancer therapy developed by Miller School Nobel laureate Andrew V. Schally, he was out of treatment options, and hope. But after his final dose of the promising drug, Chambers is feeling better.

Glenn Barber, Ph. D.

Sylvester Cancer Researcher Selected to Lead Cell Biology and Anatomy


Glen Barber, Ph.D., professor of medicine and associate director of basic research at Sylvester Comprehensive Cancer Center, has been named chairman of the Department of Cell Biology and Anatomy. The selection comes after an extensive search by W. Dalton Dietrich, Ph.D., senior associate dean for Discovery Science, and the Cell Biology Chair Search Committee, at the request of Pascal J. Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean of the Miller School.

Daisy Healey, 12, leaves her handprint on a Hyundai Sonata, an official vehicle of the Hope on Wheels tour.

Pediatric Oncologist Receives Hyundai Scholar Grant for Leukemia Research


Hyundai Motor America and its Miami-Fort Lauderdale dealers have awarded John Goldberg, M.D., assistant professor of pediatrics, a $50,000 Hyundai Scholar grant to study the anti-leukemia properties of metformin, a commonly prescribed oral medication for diabetes, in combination with other drugs.